Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 1/2013

01.01.2013 | Genetics

Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?

verfasst von: M. L. N. Deepika, K. Ranjith Reddy, V. Usha Rani, N. Balakrishna, K. Prasanna Latha, Parveen Jahan

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Polycystic ovary syndrome (PCOS) is an endocrine disorder exhibiting variable age at onset of clinical features allied with complex diseases in the later life. ACE is a pleiotropic molecule associated with various pathophysiological functions. The present study was aimed to establish the frequency of ACE I/D gene polymorphism in patients and controls and to assess the influence of this polymorphism on anthropometric and various clinical features of the condition.

Methods

ACE I/D genotyping was carried out in 259 PCOS patients and 315 healthy ultrasound scanned women of South Indian origin.

Results

The distribution of DD, ID and II genotypes in patients was 39, 37 and 24 %, whereas in the controls it was 31, 51 and 18 % respectively. Significant difference was observed in the genotypic frequency distributions between the patients and controls, however the allelic frequencies did not vary between the groups (p > 0.05). Quartile analysis revealed preponderance of DD genotype in the first two quartiles and a linear increase of II genotype from first to the last quartiles. Further, Multiple Logistic regression analysis revealed significant association of ACE I/D gene polymorphism with acanthosis and age at onset (AAO) of the syndrome (p < 0.05).

Conclusion

The present study is the first report to highlight the predisposing role of DD and protective role of ID genotype towards PCOS. Patients with single or double dose of D allele may develop PCOS symptoms at an early age and also significantly associated with acanthosis, a marker of insulin resistance.
Literatur
1.
Zurück zum Zitat Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of south eastern United States: a prospective study. J Clin Endcrinol Metab. 1998;83(9):3078–82. doi:10.1210/jc.83.9.3078.CrossRef Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in unselected black and white women of south eastern United States: a prospective study. J Clin Endcrinol Metab. 1998;83(9):3078–82. doi:10.​1210/​jc.​83.​9.​3078.CrossRef
2.
Zurück zum Zitat Farah L, Lazenby AJ, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med. 1999;44:870–4.PubMed Farah L, Lazenby AJ, Boots LR, Azziz R. Prevalence of polycystic ovary syndrome in women seeking treatment from community electrologists. Alabama Professional Electrology Association Study Group. J Reprod Med. 1999;44:870–4.PubMed
3.
Zurück zum Zitat Han S, Tan S, Elsenbruch S, Quadbeck B, Herrmarnn BL, Mann K, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res. 2005;37:438–44.CrossRef Han S, Tan S, Elsenbruch S, Quadbeck B, Herrmarnn BL, Mann K, et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia. Horm Metab Res. 2005;37:438–44.CrossRef
4.
Zurück zum Zitat Balen AH, Dunger D. Pubertal maturation of the internal genitalia. Ultrasound Obstet Gynecol. 1995;6:164–5.PubMedCrossRef Balen AH, Dunger D. Pubertal maturation of the internal genitalia. Ultrasound Obstet Gynecol. 1995;6:164–5.PubMedCrossRef
5.
Zurück zum Zitat Elting MW, Korsen TJM, Rekers-Mombarg LTM, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when aging. Hum Reprod. 2000;15:24–8.PubMedCrossRef Elting MW, Korsen TJM, Rekers-Mombarg LTM, Schoemaker J. Women with polycystic ovary syndrome gain regular menstrual cycles when aging. Hum Reprod. 2000;15:24–8.PubMedCrossRef
6.
Zurück zum Zitat Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095–105.PubMedCrossRef Ovalle F, Azziz R. Insulin resistance, polycystic ovary syndrome and type 2 diabetes mellitus. Fertil Steril. 2002;77(6):1095–105.PubMedCrossRef
7.
Zurück zum Zitat Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24(3):302–12.PubMedCrossRef Legro RS. Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev. 2003;24(3):302–12.PubMedCrossRef
8.
Zurück zum Zitat Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361(9371):1810–2.PubMedCrossRef Hardiman P, Pillay OS, Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet. 2003;361(9371):1810–2.PubMedCrossRef
9.
Zurück zum Zitat Wild S, Pierpont T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of 31 year follow-up study. Hum Fertil (Camb). 2000;3(2):101–5. PMID: 11844363.CrossRef Wild S, Pierpont T, Jacobs H, McKeigue P. Long-term consequences of polycystic ovary syndrome: results of 31 year follow-up study. Hum Fertil (Camb). 2000;3(2):101–5. PMID: 11844363.CrossRef
10.
11.
Zurück zum Zitat Giaccchetti G, Sechi LA, Rillis S. The rennin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 2005;16(3):120–6.CrossRef Giaccchetti G, Sechi LA, Rillis S. The rennin-angiotensin-aldosterone system, glucose metabolism and diabetes. Trends Endocrinol Metab. 2005;16(3):120–6.CrossRef
12.
Zurück zum Zitat Schwentner L, Wöckel A, Herr D, Wulff C. Is there a role of the local tissue RAS in the regulation of physiologic and pathophysiologic conditions in the reproductive tract? J Renin-Angiotensin-Aldosterone Syst. 2011;12(4):385–93. doi:10.1177/1470320311418140.PubMedCrossRef Schwentner L, Wöckel A, Herr D, Wulff C. Is there a role of the local tissue RAS in the regulation of physiologic and pathophysiologic conditions in the reproductive tract? J Renin-Angiotensin-Aldosterone Syst. 2011;12(4):385–93. doi:10.​1177/​1470320311418140​.PubMedCrossRef
13.
Zurück zum Zitat Yoshimura Y. The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol. 1997;18:247–91.PubMedCrossRef Yoshimura Y. The ovarian renin-angiotensin system in reproductive physiology. Front Neuroendocrinol. 1997;18:247–91.PubMedCrossRef
14.
Zurück zum Zitat Rigat B, Hubert C, Alence-Gelas F. An insetion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343–6.PubMedCrossRef Rigat B, Hubert C, Alence-Gelas F. An insetion/deletion polymorphism in the angiotensin I converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343–6.PubMedCrossRef
15.
Zurück zum Zitat Jia H, Wang B, Yu L, Jiang Z. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with polycystic ovary syndrome: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2012;0(0):1–8. doi:10.1177/1470320312452768. Jia H, Wang B, Yu L, Jiang Z. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with polycystic ovary syndrome: a meta-analysis. J Renin Angiotensin Aldosterone Syst. 2012;0(0):1–8. doi:10.​1177/​1470320312452768​.
16.
Zurück zum Zitat Celika O, Yesiladab E, Hascalika S, Celikc N, Sahind I, Keskind L, Ozerole E. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Reprod Biomed Online. 2010;20(4):492–8. PMID: 20138007.CrossRef Celika O, Yesiladab E, Hascalika S, Celikc N, Sahind I, Keskind L, Ozerole E. Angiotensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Reprod Biomed Online. 2010;20(4):492–8. PMID: 20138007.CrossRef
17.
Zurück zum Zitat Sun J, Fan H, Che Y, Cao Y, Wu X, Sun H, Liang F, Yi L, Wang Y. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls. BMC Med Genet. 2009;10:64. doi:10.1186/1471-2350-10-64.PubMedCrossRef Sun J, Fan H, Che Y, Cao Y, Wu X, Sun H, Liang F, Yi L, Wang Y. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls. BMC Med Genet. 2009;10:64. doi:10.​1186/​1471-2350-10-64.PubMedCrossRef
18.
Zurück zum Zitat Karabulut A, Turgut S, Turgut G. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2010;26(6):393–8.PubMedCrossRef Karabulut A, Turgut S, Turgut G. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome. Gynecol Endocrinol. 2010;26(6):393–8.PubMedCrossRef
19.
Zurück zum Zitat Tippisetty S, Ishaq M, Komaravalli PL, Jahan P. Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression. Eur J Dermatol. 2011;21(2):173–7.PubMed Tippisetty S, Ishaq M, Komaravalli PL, Jahan P. Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression. Eur J Dermatol. 2011;21(2):173–7.PubMed
20.
Zurück zum Zitat Bayram B, et al. Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene. 2011;489(2):86–8.PubMedCrossRef Bayram B, et al. Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS). Gene. 2011;489(2):86–8.PubMedCrossRef
21.
Zurück zum Zitat Van Sande ME, Scharpe SL, Neels HM, Van Camp KO. Distribution of Angiotensin converting enzyme in human tissues. Clin Chim Acta. 1985;147(3):255–60.PubMedCrossRef Van Sande ME, Scharpe SL, Neels HM, Van Camp KO. Distribution of Angiotensin converting enzyme in human tissues. Clin Chim Acta. 1985;147(3):255–60.PubMedCrossRef
22.
Zurück zum Zitat Plendl J, Neumiiller C, Vollmar A, Auerbach R, Sinowatz F. Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat Embryol. 1996;194:445–56.PubMedCrossRef Plendl J, Neumiiller C, Vollmar A, Auerbach R, Sinowatz F. Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat Embryol. 1996;194:445–56.PubMedCrossRef
23.
Zurück zum Zitat Acosta TJ, Berisha B, Ozawa T, Sato K, Schams D, Miyamoto A. Evidence for a local endothelin-angiotensin-atrial natriuretic peptide systemin bovine mature follicles in vitro: effects on steroid hormones and prostaglandin secretion. Biol Reprod. 1999;61(6):1419–25.PubMedCrossRef Acosta TJ, Berisha B, Ozawa T, Sato K, Schams D, Miyamoto A. Evidence for a local endothelin-angiotensin-atrial natriuretic peptide systemin bovine mature follicles in vitro: effects on steroid hormones and prostaglandin secretion. Biol Reprod. 1999;61(6):1419–25.PubMedCrossRef
24.
Zurück zum Zitat Nielsen AH, Hagemann A, Svenstrup B, Nielsen J, Poulsen K. Angiotensin II receptor density in bovine ovarian follicles relates to tissue renin and follicular size. Clin Exp Pharmacol Physiol. 1994;21(6):463–9.PubMedCrossRef Nielsen AH, Hagemann A, Svenstrup B, Nielsen J, Poulsen K. Angiotensin II receptor density in bovine ovarian follicles relates to tissue renin and follicular size. Clin Exp Pharmacol Physiol. 1994;21(6):463–9.PubMedCrossRef
25.
Zurück zum Zitat Koh WP, Yuan JM, Sun CL, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res. 2003;63:573–8.PubMed Koh WP, Yuan JM, Sun CL, et al. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res. 2003;63:573–8.PubMed
26.
Zurück zum Zitat Koika V, Georgopoulos NA, Piouka A, Roupas ND, Karela A, Armeni AK, Katsantoni E, Panidis D. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol. 2012;166(4):695–702. PMID: 22223701.PubMedCrossRef Koika V, Georgopoulos NA, Piouka A, Roupas ND, Karela A, Armeni AK, Katsantoni E, Panidis D. Increased frequency of the DI genotype of the angiotensin-I converting enzyme and association of the II genotype with insulin resistance in polycystic ovary syndrome. Eur J Endocrinol. 2012;166(4):695–702. PMID: 22223701.PubMedCrossRef
27.
Zurück zum Zitat Javaid A, Mansoor Q, Bilal N, Bilal A, Shaukat U, Ismail M. ACE gene DD genotype association with obesity in Pakistani population. Int J Bioautom. 2011;15(1):49–56. Javaid A, Mansoor Q, Bilal N, Bilal A, Shaukat U, Ismail M. ACE gene DD genotype association with obesity in Pakistani population. Int J Bioautom. 2011;15(1):49–56.
28.
Zurück zum Zitat Cao Y, Wang Y, Zhou P et al. Relationship between ACE gene polymorphism and the renin-angiotensin system in PCOS patients. Chinese Journal of Practical Gynecology and Obstetrics; 2002–11. doi:CNKI:SUN:ZGSF.0.2002-11-012. Cao Y, Wang Y, Zhou P et al. Relationship between ACE gene polymorphism and the renin-angiotensin system in PCOS patients. Chinese Journal of Practical Gynecology and Obstetrics; 2002–11. doi:CNKI:​SUN:​ZGSF.​0.​2002-11-012.
Metadaten
Titel
Do ACE I/D gene polymorphism serve as a predictive marker for age at onset in PCOS?
verfasst von
M. L. N. Deepika
K. Ranjith Reddy
V. Usha Rani
N. Balakrishna
K. Prasanna Latha
Parveen Jahan
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 1/2013
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-012-9906-8

Weitere Artikel der Ausgabe 1/2013

Journal of Assisted Reproduction and Genetics 1/2013 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.